Loading...

Follow INDIVA | Medical Cannabis Blog on Feedspot

Continue with Google
Continue with Facebook
or

Valid

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Indiva Limited – Press Release Correction LONDON, ON, Feb. 15, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSXV:NDVA) (US:NDVAF) announces a correction to its press release entitled “BNN BLOOMBERG IDENTIFIES INDIVA AS RAPIDLY GROWING IN THE CANNABIS SECTOR” issued today. The Company wishes to clarify the Company will be featured on an upcoming episode of Business Television (BTV), a program aired on BNN Bloomberg, and has not been endorsed or otherwise identified by BNN Bloomberg. BTV is a half-hour weekly investment program, which profiles emerging companies across Canada and the US to bring investors information for their portfolio. With Hosts Taylor Thoen and Jessica Katrichak, BTV interviews experts, top analysts, plus features companies at their location giving investors an insightful business perspective. BTV BROADCAST TIMES: CANADA: BNN Bloomberg – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST Bell Express Vu – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST Air Canada: TV Seatback: Business Channel U.S. National: Biz Television Network – Sun Feb. 24 @ 10:00pm & 4:30pm PST, Sat Feb. 2 @ 9:00pm PST About Indiva Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva’s wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products. Contact Information Niel Marotta, CEO, INDIVA Phone: 613-883-8541 Email: niel@indiva.com Steve Low, Investor Relations Phone: 647-620-5101 Email: slow@indiva.com   DISCLAIMER & READER ADVISORY Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the  securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S.  Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.  

The post Indiva Limited – Press Release Correction appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Cannabis users soon will be able to buy and spark up legal, made-in-London joints. You can’t legally buy recreational pot at any store in London yet, but soon Ontarians will be able to spark up legal, made-in-London joints. London-based cannabis grower Indiva has inked a deal to supply the Ontario Cannabis Store (OCS), the province’s pot wholesaler and monopoly online retailer, with pre-rolled spliffs. But unlike those doobies passed around at parties and concerts, Indiva is taking a scientific approach to its joint-making process. Not only are joints DNA-free – nobody licks the papers or handles them with bare hands – but there’s also no rolling involved in the making of each half-gram spliff. “They’re vibrated,” Melissa Kurek, Indiva’s director of operations, said of the process. Inside a windowless 27-square-metre room at Indiva’s Hargrieve Road headquarters, three workers collectively make 1,500 joints during an eight-hour shift. Outfitted in white suits, hairnets, shoe-coverings and gloves, the employees look more like scientists than professional joint makers. They start by filling a large metal bowl with pre-ground cannabis, while 453 paper shells that come pre-rolled with a filter at one end and flared at the other, are placed filter down in a honey-comb-like metal tray with the flared end up. Marijuana is spread evenly across the tray, which is placed in a machine which “cycles through different vibrational settings to fill all the cones to a consistent fill and pack,” Kurek said. A worker weighs each joint to ensure it contains a half-gram of cannabis before doing a visual inspection for any abnormalities. Finally, a staffer uses a metal poker to push in the excess paper at the end of the joint before it’s packed into a plastic container. “We do sort of a twist and fold method,” Kurek said of the final step. Three-hundred joints are packed like sardines into each container. The container goes in a zipper-sealed bag that’s placed inside a tote before it’s placed in the company’s vault, where other pot products awaiting shipment are stored. Indiva is the latest cannabis company to sign a supply agreement with the OCS, a move chief executive Niel Marotta called “gigantic.” “The OCS will be, by far, the biggest legal cannabis purchaser, at least on a wholesale basis, on the planet for the foreseeable future,” Marotta said. Available in two different strains, Indiva’s joints will be sold in packages of two through the OCS website, and eventually at brick-and-mortar marijuana retailers once they open in April. London is on track to get one of Ontario’s first 25 recreational pot shops. Christopher Comrie submitted an application to the Alcohol and Gaming Commission of Ontario (AGCO), the province’s pot regulator, to open Central Cannabis in a commercial plaza at 666 Wonderland Rd., north of Oxford Street. Indiva’s joints will appear on the OSC website in the next few weeks, said Marotta, who didn’t provide an exact date. “We want to be able to provide products to Londoners as soon as possible,” he said. With Canada’s cannabis industry projected to be worth $5 billion by 2021, according to a recent report, Indiva is turning its attention to the lucrative recreational market. Last month, the company announced a partnership with an American firm to set up an extraction operation at its south-end facility. The move comes as marijuana companies across Canada are preparing for the introduction of pot-infused edibles, concentrates and topicals to the market in the fall. “We’ll have a lot of new product introductions in 2019,” Marotta said, noting Indiva is in supply talks with at least two other provinces. “As we scale up, we’ll look to ink supply agreements with them as well,” he said. This article was originally published by The London Free Press.

The post Indiva contracted to supply joints to Ontario Cannabis Store appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Not for distribution to U.S. Newswire Services or for dissemination in the United States. BNN Bloomberg Identifies Indiva as Rapidly Growing in the Cannabis Sector LONDON, ON, Feb. 15, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSX:NDVA) (US:NDVAF):  On BNN Bloomberg this Saturday February 16 and Sunday February 17, 2019 – BTV- Business Television visits five distinctive companies in the rapidly growing cannabis sector. One of the companies identified is Indiva and the episode features our commitment to the edibles market through the upcoming release of a line of chocolates and cannabis-infused sugar and salt products. Further, President and CEO Niel Marotta discusses Indiva’s current lineup of dried flower and pre-rolls, which will soon be available through the Ontario Cannabis Store, as well as the eventual introduction of gel capsules and oil tinctures. Indiva’s segment can be seen here: See Feature BTV is a half-hour weekly investment program, which profiles emerging companies across Canada and the US to bring investors information for their portfolio. With Hosts Taylor Thoen and Jessica Katrichak, BTV interviews experts, top analysts, plus features companies at their location giving investors an insightful business perspective. BTV BROADCAST TIMES: CANADA: BNN Bloomberg – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST Bell Express Vu – Saturday Feb. 16 @ 8:00pm EST, Sunday Feb. 17 @ 4:30pm EST Air Canada: TV Seatback: Business Channel U.S. National: Biz Television Network – Sun Feb. 24 @ 10:00pm & 4:30pm PST, Sat Feb. 2 @ 9:00pm PST About Indiva Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva’s wholly owned subsidiary is licensed under the Cannabis Act.  As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products. Contact Information Niel Marotta, CEO, INDIVA Phone: 613-883-8541 Email: niel@indiva.com Steve Low, Investor Relations Phone: 647-620-5101 Email: slow@indiva.com   DISCLAIMER & READER ADVISORY Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the  securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S.  Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.  

The post Press Release – BNN Bloomberg Identifies Indiva as Rapidly Growing in the Cannabis Sector appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Now that recreational cannabis has been legalized in Canada, high quality and lab tested product has become easily available to Ontarians through the Ontario Cannabis Store (OCS) website which can be found at OCS.ca. For now, the government operated OCS offers online sales only and is currently the only place for consumers to legally purchase recreational marijuana. Bricks-and-mortar storefronts and dispensaries are set to open until April of this year. Aside from being the only legal way to buy weed, there are plenty of reasons to purchase through the OCS. This includes the assurance of lab tested products, availability of detailed product information, abundant choices and customer safety. Ordering is easy and shipping times are fast, with orders scheduled to arrive within 1-3 business days of purchase. Individual orders are capped at 30 grams of dried cannabis flower, which is also the maximum amount that can be carried legally in public, but multiple (separate) orders may be placed. Dried flower prices range from about CAD$7.50 to CAD$13.25 per gram and payments can be made with Visa, Visa Debit, Mastercard, Mastercard Debit, Amex or pre-paid credit cards. Shipping is via Canada Post and requires a flat rate fee of $5.65. At the time of writing this article, there are 75 different strains of dried cannabis flower available for purchase, but that number is set to increase to around 150 soon. What does the OCS sell? The menu at the OCS is extensive, including dried cannabis flower (buds), pre-rolled joints, gel capsules, and cannabis oils. Consumers can even buy seeds and cannabis accessories like pipes, bongs, vapes, papers, filters, storage items, cleaning supplies and more. The actual cannabis products are intuitively arranged into categories so consumers can easily find what they’re looking for, and individual product types are also separated into the three main categories of cannabis strains – Indica, Sativa and Hybrids. The store also provides a large learning section dedicated to providing customers with cannabis facts, tips and legal rules to help educate consumers about how cannabis works, how to consume it safely and what effects to expect. There is an FAQ section that provides answers to most questions consumers might have about cannabis or making a purchase through the OCS. Also included is a guide to choosing the right cannabis strain for your needs. How does ordering from the OCS work? To view the OCS website or place an order, consumers must verify they are over 19 years of age. Customers do not need to create an account to place an order, but a valid ID will be required at the time of delivery. Order processing is handled by Ottawa’s own Shopify to ensure a smooth ordering and payment process. A valid Visa, Visa Debit, Mastercard, Mastercard Debit, American Express or pre-paid credit is required to complete payment but support for other payment options will be added down the road. Orders arrive in non-descript Canada Post boxes which contain the products along with a leaflet (in both English and French) containing information about cannabis consumption, effects, laws and health hazards. Also contained is the actual cannabis product, packaged in very sterile, medical looking jars, bags or other containers that are sealed by a holographic government excise seal. Steps to making a purchase with the OCS Visit the Ontario Cannabis Store website at OCS.ca. Mobile access is through a web browser only – there is no OCS app currently available Complete the age verification to enter the site Choose to visit the learning sections or head straight to ordering a product (OCSlearn.ca is a great source for valuable information about cannabis) Browse and select any products you’d like to order by adding them to cart Each cannabis product page shows valuable information about the product, including brand, licensed producer, product description, price (including taxes), THC and CBD percentages, plant type, contained terpenes and a description of the aroma and taste customers can expect Sticking with public carry laws, the maximum order allowed is 30 grams of cannabis at a single time. However, several orders may be placed. Once ready to checkout, customers may currently only make payments using Visa, Visa Debit, Mastercard, Mastercard Debit, AMEX or pre-paid credit cars but additional payment options will be made available in the future Before completing checkout, customers will be required to confirm they are 19 years of age or older and must accept the OCS terms and conditions There is currently only one shipping option available through Canada Post and it costs a flat rate of CAD$5.65 (taxes included). Orders will arrive between 1-3 business days Purchases from the OCS will be delivered in plain packaging and handed over only to persons who are 19 years of age or older. If the person who is accepting delivery of the package looks under the age of 25, a valid ID will be required for verification. If no one answers the door to receive the package, it will be returned to the nearest post office. Note that condominium concierges are not able to accept deliveries from the OCS The OCS currently offers a 14-day Return Policy for all cannabis product orders. Any cannabis products may be returned for refund within 14 days of delivery provided they are in their original condition (unopened). Payments will be refunded to the original payment method that was used to make the purchase. All accessories are final sale and returns are not accepted Choosing products Choosing which strains of cannabis to order can be a tough decision when there are so many different varieties to choose from. This is especially true for customers not familiar with cannabis. First, we suggest learning about the different types of products, like dried flower, pre-rolls, capsules or oils – and choosing the type that best suits your needs. Keep in mind that oils and capsules will deliver a different (stronger) effect than dried flower or pre-rolled joints. Once you’ve narrowed it down, it’s recommended to spend some time browsing through all the product […]

The post The Indiva Guide to the Ontario Cannabis Store appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Not for distribution to U.S. Newswire Services or for dissemination in the United States. INDIVA announces initial supply agreement with the Ontario Cannabis Store LONDON, ON – Friday February 8, 2019: Indiva Limited (the “Company” or “Indiva”) (TSX:NDVA) (US:NDVAF) is excited to announce its first supply agreement with the Ontario Cannabis Retail Corporation (“OCRC”), doing business as the Ontario Cannabis Store (“OCS”). This initial partnership will consist of two strains of pre-rolls, manufactured and shipped with care from Indiva’s London, Ontario facility. The products will be available on OCS.ca and to OCS Wholesale clients starting in April 2019. “We are thrilled to be one of the first licensed producers that will have products on OCS shelves in time for the grand opening of all Ontario stores April 1st,” said Niel Marotta, President and CEO of Indiva. “I’m very thankful for our team’s hard work in getting Indiva to this milestone.”   Contact Information Niel Marotta, CEO, INDIVA Phone: 613-883-8541 Email: niel@indiva.com Steve Low, Investor Relations Phone: 647-620-5101 Email: slow@indiva.com   About Indiva Indiva’s wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products. Indiva’s mission is to offer cannabis products that have  a positive impact, improving lives and communities. Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.   DISCLAIMER & READER ADVISORY Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the  securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S.  Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.  

The post Press Release – INDIVA announces initial supply agreement with the Ontario Cannabis Store appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Not for distribution to U.S. Newswire Services or for dissemination in the United States.   LONDON, ON, Feb. 8, 2019 /CNW/ – Indiva Limited (the “Company” or “Indiva“) (TSX:NDVA) (US:NDVAF) is excited to announce its first supply agreement with the Ontario Cannabis Retail Corporation (“OCRC”), doing business as the Ontario Cannabis Store (“OCS”). This initial partnership will consist of two strains of pre-rolls, manufactured and shipped with care from Indiva’s London, Ontario facility. The products will be available on OCS.ca and to OCS Wholesale clients starting in April 2019. “We are thrilled to be one of the first licensed producers that will have products on OCS shelves in time for the grand opening of all Ontario stores April 1st,” said Niel Marotta, President and CEO of Indiva. “I’m very thankful for our team’s hard work in getting Indiva to this milestone.” About IndivaIndiva’s wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva’s mission is to offer cannabis products that have a positive impact, improving lives and communities. Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products. DISCLAIMER & READER ADVISORYNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to TSX Venture Exchange approval of the transactions contemplated herein, future international expansion, future product offerings, future entry into additional markets, changes to laws and regulations in Canada and internationally, and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary corporate, regulatory and other third parties approvals; licensing and other risks associated with regulated ACMPR entities; and completion of satisfactory due diligence. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United Statesor to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.   For further information: Niel Marotta, CEO, INDIVA, Phone: 613-883-8541, Email: niel@indiva.com; Steve Low, Investor Relations, Phone: 647-620-5101, Email: slow@indiva.com nbsp;

The post Press Release – Indiva announces initial supply agreement with the Ontario Cannabis Store appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The edibles market in Canada is expected to be enormous and Indiva is poised to be the one-to-watch when it comes to this landscape. Niel Marotta, Indiva’s President and CEO, recently appeared on Midas Letter Live to discuss the future of this sector and share some (non-infused) Bhang chocolate with host James West.  Transcript: James West: Niel Marotta joins me now from Indiva. Niel, welcome back. Niel Marotta: Thank you. Thanks for having me. James West: Niel, you brought some treats. Niel Marotta: I did. James West: And they are loaded with hallucinogenic chemicals, I understand? Niel Marotta: Not yet, no. James West: Oh… Niel Marotta: If they will be hallucinogenic, and maybe that’s a whole other ball of wax. James West: Right, so they got some weed in them. Niel Marotta: Yeah, they do not yet, but we have here – James West: Because that would be illegal. Niel Marotta: We’re going to show these, but these are a couple of Bhang chocolate samples. We’re going to have a couple of pop-up shops handing these out February 15th, 16th in Toronto. We were handing these out at the LIFT conference. They are unmedicated, you know, we’re not allowed to sell – James West: They’re unmedicated? Niel Marotta: At this point, they are unmedicated, so no THC, no CBD, so far. James West: Thank you. Just kidding, I love dark chocolate. Niel Marotta: I tried, James, for you, but you know…. James West: So this is the actual chocolate you’re going to have? Niel Marotta: It is. They’re childproof, so you might be able to get it open with your teeth, but these are the – you may have some scissors kicking around here… James West: Damn! Okay. I’m going to pull out my incisors. Niel Marotta: I think you’ve got it if you’ve got a little cut there, it should be able to rip open, James West: Childproof, well, it certainly checks the childproof box. I’m going to try a reverse pressure move. Niel Marotta: So basically, maybe we need some scissors. Medic? James West: Medic! Can we get a scalpel over here? [laughter] Oh there we go, all right. Look at that. Niel Marotta: After all that, I sincerely hope you like it. James West: Exactly. Nobody under 520 pounds will be able to get this open. Niel Marotta: No. No kids will be getting this open; that’s important. So – James West: That’s true. So how are we going to get this stuff to the kids? No just kidding – inappropriate, I realize that. Okay, so is this actual chocolate that you’re going to use? Niel Marotta: It is. Yeah, that’s the formulation for the dark chocolate, one of their 14 flavours. This is the formulation for the milk chocolate – James West: Oooh, that’s good. Niel Marotta: Yeah, well, thank you. James West: Mmm. Niel Marotta: I wish I could say I had anything to do with the recipe other than just licensing it, but we’re really proud that we have licensed the Bhang products, really the most delicious, the most award-winning cannabis chocolate on the planet. And so we’ll be bringing that to Canadians in the Fall as soon as we see the final regs to know when we can introduce those products. So we – go ahead – you’re still chewing! James West: Well, I was going to say, I don’t mind talking with my mouth full, everybody in my house does it; we’re basically a nation of swine, but – what can I say. So the claim that this is the best chocolate in all of Canadian cannabis is one that I’ve heard a few times. Niel Marotta: I’m sure you have. James West: So how do you actually determine who’s got the better chocolate bar? Niel Marotta: Well, Bhang really has won all kinds of awards, Cannabis Cup awards, etcetera, in the US over the last several years. And so certainly, because we haven’t made legally any cannabis chocolate in Canada I guess that’s legitimacy behind the claim that this is award-winning chocolate in other jurisdictions where edibles have been legal for some time, like California. And so now that it looks like by October, maybe there’ll be some delay, which, you know, we don’t think hurts Indiva too much, it just gives us a chance to build more inventory. But we’re excited to bring these products to market. James West: So wait a sec – did you say there’s a delay being floated? Niel Marotta: Well, there was something on Bloomberg yesterday about whether October 17th would be the exact date. James West: Oh, Bloomberg, what do they know. Just kidding. Niel Marotta: Ha ha, it was a comment from Bill Blair, so we take that pretty seriously. James West: Bill Blair, wasn’t he a former cop. Niel Marotta: I don’t know, you tell me. I think so, yes, that’s my understanding. I’m no expert. James West: Oh boy, I’m gonna have fun with him when I get him on the show, if I ever do. Anyways, so, oh, look at that, I’m sitting somewhat out of frame. So what are you anticipating in the way of sales initially upon the legalization of edibles? Do you expect that your sales are going to be, first of all, mostly medical versus recreational, is it only recreational, and what kind of volume do you anticipate? Niel Marotta: Specifically on the edibles side of things, we know there’ll be some medical demand; I mean, this has been settled in Canada, the RV Smith case, patients have the right to consume cannabis in whatever form that they like. So we’ll sell into that channel as we’re permitted. But definitely on the recreational side, we know from, let’s say the illicit market, and a lot of dispensaries that used to be open and by and large are now closed, edibles is a pretty, let’s say, 20 percent of revenue and looking at mature markets […]

The post The Big Bhang Theory: Why Indiva is Poised to Be a Leader in the Edibles Market appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

With an eye on the lucrative market for cannabis-infused edibles, a London-based pot producer is tapping an American company to set up an extraction operation at its south-end facility. The move comes as marijuana companies across Canada are preparing for the introduction of edibles, concentrates and topicals to the market in the fall. The federal government pledged to greenlight the sale of the products by Oct. 17 — one year after recreational pot was legalized — but uncertainty remains about when consumers will be able to munch pot brownies and vape cannabis concentrates. Indiva announced this week it’s working with Lucid Lab Group, a Seattle-based maker of cannabis extraction and refinement technologies. “We know we have an opportunity to take more of a leadership role on the edibles side because we’ve been aggressive,” Indiva chief executive Niel Marotta said Friday. “We want to be ready for next fall for sure.” Indiva previously struck a licensing deal with Ruby Edibles, a company that makes cannabis-infused sugar and salt. The company also has a joint with Bhang, a U.S. manufacturer of cannabis chocolates and vape pens, which gives it the right to produce and sell products under that brand. Bill Blair, the country’s pot point-man, said this week the government is committed to completing the final regulations for edibles by Oct. 17, but he suggested there could be a gap between the products getting approval for sale and when they actually hit the shelves. Blair, also the minister of border security and organized crime reduction, cited the 17-week gap between the federal government passing the law legalizing recreational marijuana last June before sales of the drug began on Oct. 17, 2018. This article was originally published by The London Free Press.

The post Indiva Sets Up Cannabis Extraction Operation at London Facility appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

As Canada prepares for the next wave of legalization, most Canadians that have never tried extracts and edibles are about to be enlightened as they’ve never been before. Products that include vape pens and a veritable buffet of edible products are destined to adorn store shelves in the near future. “Premium flower will always be enjoyed, but it’s the [most challenging] way to consume,” said Stephen Heimburger, President of Lucid Lab Group in an interview for Indiva. “You [also] have smoke, combustion, it’s the least healthy way, so concentrates and edibles offer solutions to that problem. They also offer the ability to control and measure dosing, and generally, it’s a cleaner product overall.” Lucid is a self-described technology company that provides solutions across the cannabis industry. The company is overseeing the design and construction of Indiva’s upcoming extraction facility, which will be its hub for all edibles and concentrates manufacturing. Heimburger also knows, from his experiences in the U.S. market, that the sales potential for concentrates and edibles is staggering. “We’ve seen in Washington State a 30 percent increase in concentrate sales and that was directly taken away from flower sales,” he said. Lucid Labs doesn’t just create technology for emerging cannabis regions, they also have their own line of premium extracts available in the U.S. market. “We work with equipment manufacturers to modify and improve equipment for the industry, we also work on the consulting side in parallel with that equipment. We round it all out with a consumer brand [that’s] available in Nevada right now, Washington soon, and we’ll be launching in California and Florida sometime in 2019.” Indiva is excited to partner with Lucid Lab Group on our upcoming extraction facility, which is scheduled for Q2 2019.

The post Indiva is Completely Lucid Over Cannabis Extraction appeared first on INDIVA.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Cannabis edibles allow users to get the effects of marijuana without the necessity to smoke or vaporize their weed and concentrates. The effects are stronger, they last longer and there are no fancy gadgets or rolling skills required. You won’t end up coughing because you took too big a toke and the act of physically ingesting edibles is natural because we all know how to eat and drink, right? Cannabis edibles can also be made at home from dried flower, cannabutter or cannabis oils.  There are even ‘ready-for-purchase units like the LEVO I Oil Infuser that allow you to easily create cannabis infused oils and butter. One thing you do need to keep in mind though is that the effects of eating weed are different than smoking it and deliver a more powerful body high. Cannabis edibles can sometimes have a bit of a learning curve, albeit it an easy one, and dosing needs to be understood to get the most out of the experience while not overdoing it. Why Do Cannabis Edibles Deliver a Stronger High? The main psychoactive ingredient in cannabis is Delta-9-tetrahydrocannabinol (THC). Once ingested, your body begins to metabolize delta-9-THC into its cousin molecule 11-hydroxy-THC which has increased psychoactive properties. The higher the percentage of the latter, the stronger you the effects you will feel. Smoking Vs. Edibles When you smoke cannabis, the THC arrives rapidly in the bloodstream via your lungs and you get high quickly. But because the delta-9-THC molecule is an oil-soluble compound, it doesn’t really metabolize well in the bloodstream due to the high water content of blood. This means that when you smoke cannabis, the THC quickly binds with the endocannabinoid receptors in the body and doesn’t have much of a chance to be metabolized into its cousin molecule, 11-hydroxy-THC. You feel the effects quicker, but they are not as strong and only last a couple of hours. When you eat cannabis though, the THC is absorbed through your bodies digestive system in differing degrees, where it is metabolized by your gastrointestinal tract and then your liver. These are much more efficient at metabolizing delta-9-THC into 11-hydroxy-THC by binding it to a glucuronide compound, which allows it to pass through the blood-brain barrier much more easily. Metabolization has longer to occur which means the concentration of 11-hydroxy-THC ends up being much higher. 11-hydroxy-THC doesn’t have a lot of scientific research surrounding it, but it is known to deliver stronger, more psychoactive effects exceeding those of delta-9-THC. That’s why when you eat cannabis instead of smoke it, you end up with a more intense high that situates itself throughout the entire body. Understanding Absorption Rates of Cannabis Edibles A lot of people assume that the effects levels of all edibles are the same at equal doses. That needs to be cleared up right now because not all edibles deliver the same effects. An edible like a brownie may take a lot longer to absorb, and it metabolizes differently than a product like a lozenge, candy or tincture. Metabolization varies due to different edibles having varying absorption rates which are caused by how they’re ingested. The absorption rate of a specific edible is determined by its bioavailability and how fully it metabolizes. Bioavailability refers to the rate at which a drug is absorbed into the body’s circulatory system and is used to determine correct dosing guidelines. There are many things that can have an effect on bioavailability such as your metabolic rate, age, health, other drug or food interactions, even how much you’ve slept, but very important is how you ingested the drug. Gastro-Uptake Edibles Edibles which are absorbed through your stomach (cookies, snacks, pills etc.) are called ‘gastro-uptake edibles’ and require processing in your liver before they end up in your bloodstream. After the THC has made it through the small intestine and then the liver, it will absorb into the bloodstream and attach to fat cells and other nutrients. This absorption method often requires more time before effects are felt but also delivers effects that may last a lot longer. Gastro-uptake edibles typically have a bioavailability score between 4 and 12 percent, meaning only a portion of the total cannabinoid content will actually make it to your bloodstream. Sublingual Edibles A more efficient edible (in terms of bioavailability) is called a ‘sublingual edible’. Examples of these are lozenges, tinctures, beverages and gummies because they mostly get absorbed before ending up in your digestive tract. This is because the tissue in your mouth is highly permeable and great at absorbing quickly, with under the tongue being the best. Sublingual edibles, like tinctures, are felt in much less time (sometimes within minutes) and have a bioavailability score of between 50 – 75 percent. Sublingual dosing is more predictable and easier to manage because there are far fewer variables that can affect the outcome. Recommended standard doses for sublingual edibles are around 1 -2 mg compared to the standard 10 mg dose for gastro-uptake edibles. Technology for Better Cannabis Edibles Even though a cannabis edibles market is yet to be realized, there has been lots of research into creating better edibles. An example of this is a new type of cannabis edible from DeepCell Industries and Canadian Licensed Producer Indiva Ltd. Their revolutionary Crystal Fusion™ technology, branded as Ruby Cannabis Sugar™, mechanically fuses cannabinoids with sucrose to create a shelf-stable and water-soluble cannabis-infused sugar for use as a regular sugar substitute. It also allows for a huge diversity of cannabis-infused edibles and drinks that taste the same as their virgin counterparts. Crystal Fusion™ technology is game-changing and will modify the way we think about cannabis edibles.

The post Building a Better Brownie: Why Edibles Will Be Huge appeared first on INDIVA.

Read Full Article

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview